Aura Biosciences ($AURA) Insider Trading & Smart Money Activity

Aura Biosciences, Inc. · Biotechnology · Latest filing Jun 16, 2026

Aura Biosciences, Inc. ($AURA) has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($164.66K), net -$164.66K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$164.66K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

AURA insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 2 · $164.66K 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AURA insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Anthony GibneyChief Financial and Business Officer. Sell (Open-market sale) 12.82K sh $82.33K —
Insider Anthony GibneyChief Financial and Business Officer. Sell (Open-market sale) 12.82K sh $82.33K —

1W / 1M / 6M = how AURA moved from the trade or filing date.

Insider trading in AURA: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Anthony Gibney Chief Financial and Business Officer. 2 -$164.66K Jun 16, 2026

Frequently asked questions

Are AURA insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $164.66K, a net -$164.66K.

What is the latest insider trade in AURA?

Anthony Gibney, Chief Financial and Business Officer. filed a sell (open-market sale) of 12.82K sh worth $82.33K on Jun 16, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text